These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36598161)

  • 1. Multi-modality management of hypertrophic cardiomyopathy.
    Rao SJ; Iqbal SB; Kanwal AS; Aronow WS; Naidu SS
    Hosp Pract (1995); 2023 Feb; 51(1):2-11. PubMed ID: 36598161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy.
    Scholtz S; Rudolph V; Reil JC
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions.
    Dong T; Alencherry B; Ospina S; Desai MY
    Drug Des Devel Ther; 2023; 17():1097-1106. PubMed ID: 37064432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstructive hypertrophic cardiomyopathy: a review of new therapies.
    Mehra N; Ali AH; Desai MY
    Future Cardiol; 2023 Oct; 19(13):661-670. PubMed ID: 37933625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive therapies for symptomatic obstructive hypertrophic cardiomyopathy.
    Mehra N; Veselka J; Smedira N; Desai MY
    Prog Cardiovasc Dis; 2023; 80():46-52. PubMed ID: 37652213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy.
    Packard E; de Feria A; Peshin S; Reza N; Owens AT
    Cardiol Ther; 2022 Dec; 11(4):491-507. PubMed ID: 36243823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic management of hypertrophic obstructive cardiomyopathy: alcohol septal ablation or surgical myomectomy?
    Noble S; Sigwart U
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1041-4. PubMed ID: 25039895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of mavacamten for the treatment of symptomatic obstructive hypertrophic cardiomyopathy in adults.
    Dong T; Nissen S; Ospina S; Desai MY
    Expert Rev Cardiovasc Ther; 2023 Jan; 21(1):5-13. PubMed ID: 36522857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy.
    Zampieri M; Argirò A; Marchi A; Berteotti M; Targetti M; Fornaro A; Tomberli A; Stefàno P; Marchionni N; Olivotto I
    Curr Cardiol Rep; 2021 Jun; 23(7):79. PubMed ID: 34081217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current state of the roles of alcohol septal ablation and surgical myectomy in the treatment of hypertrophic obstructive cardiomyopathy.
    Douglas JS
    Cardiovasc Diagn Ther; 2020 Feb; 10(1):36-44. PubMed ID: 32175226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team.
    Pelliccia F; Alfieri O; Calabrò P; Cecchi F; Ferrazzi P; Gragnano F; Kaski JP; Limongelli G; Maron M; Rapezzi C; Seggewiss H; Yacoub MH; Olivotto I
    Int J Cardiol; 2020 Apr; 304():86-92. PubMed ID: 31983465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
    Maron BJ; Maron MS; Wigle ED; Braunwald E
    J Am Coll Cardiol; 2009 Jul; 54(3):191-200. PubMed ID: 19589431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy: the future of treatment.
    Tuohy CV; Kaul S; Song HK; Nazer B; Heitner SB
    Eur J Heart Fail; 2020 Feb; 22(2):228-240. PubMed ID: 31919938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy?
    Knyshov G; Lazoryshynets V; Rudenko K; Kravchuk B; Beshlyaga V; Zalevsky V; Rasputnyak O; Batsak B
    Interact Cardiovasc Thorac Surg; 2013 Jan; 16(1):5-9. PubMed ID: 23027595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mavacamten: A Novel Agent for Hypertrophic Cardiomyopathy.
    Chase Cole J; Benvie SF; DeLosSantos M
    Clin Ther; 2024 Apr; 46(4):368-373. PubMed ID: 38508915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy.
    Desai MY; Owens A; Geske JB; Wolski K; Naidu SS; Smedira NG; Cremer PC; Schaff H; McErlean E; Sewell C; Li W; Sterling L; Lampl K; Edelberg JM; Sehnert AJ; Nissen SE
    J Am Coll Cardiol; 2022 Jul; 80(2):95-108. PubMed ID: 35798455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy.
    Sawan MA; Prabakaran S; D'Souza M; Behbahani-Nejad O; Gold ME; Williams BR; Bilen O
    Clin Cardiol; 2024 Jan; 47(1):e24207. PubMed ID: 38269637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study.
    Cremer PC; Geske JB; Owens A; Jaber WA; Harb SC; Saberi S; Wang A; Sherrid M; Naidu SS; Schaff H; Smedira NG; Wang Q; Wolski K; Lampl KL; Sehnert AJ; Nissen SE; Desai MY
    Circ Cardiovasc Imaging; 2022 Dec; 15(12):e014986. PubMed ID: 36335645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent outflow tract obstruction in hypertrophic cardiomyopathy: Clinical characteristics and outcomes of septal myectomy.
    Cui H; Schaff HV; Nishimura RA; Dearani JA; Geske JB; Ommen SR
    J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1863-1869.e1. PubMed ID: 33468328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy].
    Argirò A; Zampieri M; Marchi A; Del Franco A; Pàlinkàs ED; Biagioni G; Chiti C; Mazzoni C; Fornaro A; Targetti M; Cappelli F; Olivotto I
    G Ital Cardiol (Rome); 2023 Oct; 24(10):792-799. PubMed ID: 37767831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.